Motley Fool Australia

Botanix Pharmaceuticals Ltd (ASX: BOT) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover
As at

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $136.18 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 972.70 million
Earnings per share -0.018
Dividend per share N/A
Year To Date Return 70.73%
Earnings Yield N/A
Franking N/A

Botanix Pharmaceuticals Ltd (ASX: BOT) Latest News

marijuana leaf with upward facing arrow

Why the Botanix (ASX:BOT) share price is 15% higher today

More »

increasing cannabis asx share price represented by growing coin piles with cannabis plants on top

The Botanix (ASX:BOT) share price is soaring 15% higher today. Here’s why.

More »

soaring hydrix share price represented by doctor riding on top of heart high up in the clouds

Why I think these small cap ASX shares will perform in 2021

More »

ASX Pot Stocks

This ASX cannabis share just hit a milestone

More »

Medical Cannabis, Doctor, Marijuana

What’s in store for these 4 ASX cannabis shares in 2020?

More »

marijuana leaf with upward facing arrow

How did these ASX cannabis shares perform in 2019?

More »

increasing cannabis asx share price represented by growing coin piles with cannabis plants on top

Why these ASX cannabis shares are starting the week on a high

More »

ASX Pot Stocks

Which ASX cannabis shares should you buy in November?

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Botanix Pharmaceuticals Ltd (ASX: BOT)

Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, andBTX 1701 - Mild Acne.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Dec 2020 $0.14 $0.01 7.41% 2,922,678 $0.14 $0.14 $0.14
02 Dec 2020 $0.14 $-0.01 -7.14% 5,172,056 $0.15 $0.15 $0.14
01 Dec 2020 $0.14 $0.01 7.69% 3,067,237 $0.13 $0.14 $0.13
30 Nov 2020 $0.13 $-0.01 -7.14% 13,436,646 $0.14 $0.15 $0.13
27 Nov 2020 $0.14 $0.02 16.00% 3,757,824 $0.13 $0.14 $0.13
26 Nov 2020 $0.13 $0.01 8.33% 3,173,602 $0.13 $0.13 $0.12
25 Nov 2020 $0.12 $-0.01 -7.69% 5,484,419 $0.13 $0.13 $0.12
24 Nov 2020 $0.13 $0.00 0.00% 11,430,376 $0.13 $0.14 $0.13
23 Nov 2020 $0.13 $0.02 17.39% 10,455,536 $0.12 $0.14 $0.12
20 Nov 2020 $0.12 $0.00 0.00% 2,973,748 $0.12 $0.13 $0.12
19 Nov 2020 $0.12 $0.02 19.05% 3,664,786 $0.11 $0.12 $0.11
18 Nov 2020 $0.11 $0.00 0.00% 1,036,078 $0.11 $0.11 $0.11
17 Nov 2020 $0.11 $-0.01 -9.09% 5,801,619 $0.11 $0.12 $0.11
16 Nov 2020 $0.11 $0.01 9.52% 330,938 $0.11 $0.11 $0.11
13 Nov 2020 $0.11 $0.00 0.00% 717,733 $0.11 $0.11 $0.11
12 Nov 2020 $0.11 $0.00 0.00% 2,234,967 $0.11 $0.11 $0.10
11 Nov 2020 $0.11 $0.01 10.53% 7,909,874 $0.11 $0.12 $0.11
10 Nov 2020 $0.10 $0.00 0.00% 1,300,605 $0.10 $0.10 $0.10
09 Nov 2020 $0.09 $0.00 0.00% 2,640,501 $0.09 $0.10 $0.09
06 Nov 2020 $0.09 $0.00 0.00% 1,782,387 $0.09 $0.09 $0.09
05 Nov 2020 $0.09 $0.00 0.00% 923,465 $0.09 $0.09 $0.09
04 Nov 2020 $0.09 $0.00 0.00% 2,513,353 $0.09 $0.09 $0.09
03 Nov 2020 $0.09 $0.00 0.00% 2,374,464 $0.09 $0.09 $0.09
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
30 Jun 2020 Stewart Washer Issued 4 $189,676
30 Jun 2020 H. William Bosch Issued 4 $189,676
30 Jun 2020 Michael Thurn Issued 11 $436,255
30 Jun 2020 Vince Ippolito Issued 17 $701,801
08 May 2020 Michael Thurn Expiry 2 $129,727
21 Feb 2020 Stewart Washer Expiry 1 $88,000
11 Dec 2019 Robert (Rob) Towner Transfer 400 $27,000
10 Dec 2019 Michael Thurn Exercise 1 $90,000
10 Dec 2019 Michael Thurn Buy 249 $22,490
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Matthew (Matt) Callahan Non-Executive Director Feb 2020
Dr Stewart James Washer Non-Executive Director Feb 2019
Dr H. William Bosch Executive Director Jul 2016
Dr Michael Thurn Head of Australian Operations,Executive Director Feb 2019
Mr Vince Ippolito President,Executive Chairman,Executive Director May 2019
Mr Simon Lee Robertson Company Secretary Feb 2017
Simon Lee Robertson Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Shenasaby Investments Pty Ltd 70,738,307 7.27%
Caperi Pty Ltd 59,573,784 6.12%
Dr Henry William Bosch 16,000,000 1.64%
Yarraandoo Pty Ltd 10,000,000 1.03%
Sweet As Developments Pty Lt 9,815,455 1.01%
Citicorp Nominees Pty Limited 9,307,982 0.96%
Mr Ka Kian Lim 9,263,000 0.95%
Zenith Pacific Limited 9,000,000 0.93%
Zanya Nminees Pty Ld 8,584,545 0.88%
Jp Morgan Nominees Australia Pty Limited 7,756,446 0.80%
Mr Ancuan Lim 7,672,000 0.79%
HSBC Custody Nominees (Australia) Limited 7,315,893 0.75%
T T Nicholls Pty Ltd 7,000,000 0.72%
Mr Michael William Gaule 6,384,494 0.66%
Splendid Stuff Pty Ltd 6,242,156 0.64%
J & N Weston Investments Pty Ltd 5,650,000 0.58%
Mr Stephane Nicolas Fayd'Herbe 5,625,000 0.58%
BNP Paribas Nominees Pty Ltd 5,435,688 0.56%
Mr Brendan Paul Cooper 5,373,413 0.55%
Argonaut Investments Pty Ltd 5,000,000 0.51%
Show more